CoChat

Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis

Open access
Chang, James D., Sukhova, Galina K., Libby, Peter, Schvartz, Eugenia, Lichtenstein, Alice H., Field, Seth J., Kennedy, Caitlin, Madhavarapu, Swetha, Luo, Ji, Wu, Dianqing, Cantley, Lewis C. · 2007 · Proceedings of the National Academy of Sciences
Cited by 104

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Inflammatory cell activation by chemokines requires intracellular signaling through phosphoinositide 3-kinase (PI3-kinase) and the PI3-kinase-dependent protein serine/threonine kinase Akt. Atherosclerosis is a chronic inflammatory process driven by oxidatively modified (atherogenic) lipoproteins, chemokines, and other agonists that activate PI3-kinase. Here we show that macrophage PI3-kinase/Akt is activated by oxidized low-density lipoprotein, inflammatory chemokines, and angiotensin II. This activation is markedly reduced or absent in macrophages lacking p110γ, the catalytic subunit of class Ib PI3-kinase. We further demonstrate activation of macrophage/foam cell PI3-kinase/Akt in atherosclerotic plaques from apolipoprotein E (apoE)-null mice, which manifest an aggressive form of atherosclerosis, whereas activation of PI3-kinase/Akt was undetectable in lesions from apoE-null mice lacking p110γ despite the presence of class Ia PI3-kinase. Moreover, plaques were significantly smaller in apoE −/− p110γ −/− mice than in apoE −/− p110γ +/+ or apoE −/− p110γ +/− mice at all ages studied. In marked contrast to the embryonic lethality seen in mice lacking class Ia PI3-kinase, germ-line deletion of p110γ results in mice that exhibit normal viability, longevity, and fertility, with relatively well tolerated defects in innate immune and inflammatory responses that may play a role in diseases such as atherosclerosis and multiple sclerosis. Our results not only shed mechanistic light on inflammatory signaling during atherogenesis, but further identify p110γ as a possible target for pharmacological intervention in the primary and secondary prevention of human atherosclerotic cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0702663104

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 104

Metadata

Authors
Chang, J. D., Sukhova, G. K., Libby, P., Schvartz, E., Lichtenstein, A. H., Field, S. J., Kennedy, C., Madhavarapu, S., Luo, J., Wu, D., & Cantley, L. C.
Venue
Proceedings of the National Academy of Sciences
Published
2007-05-08
Volume
104
Issue
19
Pages
8077-8082
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2059839442
Cited by
104
References
3
FWCI
2.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis. https://app.cochat.ai/papers/10.1073/pnas.0702663104
The paper
Chang, J. D., Sukhova, G. K., Libby, P., Schvartz, E., Lichtenstein, A. H., Field, S. J., Kennedy, C., Madhavarapu, S., Luo, J., Wu, D., & Cantley, L. C. (2007). Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0702663104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.